Related Experiment Video
Updated: Apr 23, 2026

Collection, Isolation, and Flow Cytometric Analysis of Human Endocervical Samples
Published on: July 6, 2014
Serum Folate and Cobalamin Levels in Women Using Combined Contraceptive Vaginal Ring
Combined contraceptive vaginal rings did not affect serum folate or cobalamin levels in healthy users. This hormonal contraception is suitable for women with vitamin B12 deficiency or specific dietary habits.
Area of Science:
- Reproductive Health
- Nutritional Biochemistry
- Endocrinology
Background:
- Combined contraceptive vaginal rings are widely used for hormonal contraception.
- Serum concentrations of folate and cobalamin (vitamin B12) are crucial for overall health.
- Potential interactions between hormonal contraceptives and vitamin metabolism warrant investigation.
Purpose of the Study:
- To evaluate the impact of combined contraceptive vaginal rings on serum folate and cobalamin levels.
- To assess the safety of these contraceptives in women with potential vitamin deficiencies.
- To understand vitamin B12 metabolism in the context of exogenous estrogen use.
Main Methods:
- A case-control study involving 45 healthy female users of combined contraceptive vaginal rings and 45 controls.
- Serum cobalamin and folate levels were measured.
- Factors known to interfere with vitamin metabolism were controlled.
Main Results:
- No significant difference in serum cobalamin or folate levels was observed between users and controls.
- Dietary habits (vegetarian), smoking, and obesity did not significantly influence vitamin levels in this context.
Conclusions:
- Combined contraceptive vaginal rings do not adversely affect serum folate and cobalamin concentrations.
- These vaginal rings are a suitable hormonal contraceptive option for women with pre-existing cobalamin deficiency or restrictive diets.
- Exogenous estrogens in vaginal rings do not appear to interfere with vitamin B12 metabolism.
More Related Videos
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
03:19Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
Related Concept Videos
Birth Control Methods
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of...
Intrauterine Drug Delivery Systems